As of 2025-01-15, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (61.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.54 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -11505.6%.
The range of the Relative Valuation is (47.65) - (66.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 26.4x | 23.7x |
| Forward P/E multiples | 18.7x - 26.2x | 24.6x |
| Fair Price | (47.65) - (66.75) | (61.48) |
| Upside | -8941.1% - -12483.2% | -11505.6% |
| Date | P/E |
| 2025-01-13 | -0.21 |
| 2025-01-10 | -0.21 |
| 2025-01-08 | -0.21 |
| 2025-01-07 | -0.21 |
| 2025-01-06 | -0.21 |
| 2025-01-03 | -0.21 |
| 2025-01-02 | -0.21 |
| 2024-12-31 | -0.21 |
| 2024-12-30 | -0.21 |
| 2024-12-27 | -0.15 |
| 2024-12-26 | -0.13 |
| 2024-12-24 | -0.10 |
| 2024-12-23 | -0.09 |
| 2024-12-20 | -0.09 |
| 2024-12-19 | -0.09 |
| 2024-12-18 | -0.10 |
| 2024-12-17 | -0.10 |
| 2024-12-16 | -0.10 |
| 2024-12-13 | -0.10 |
| 2024-12-12 | -0.11 |
| 2024-12-11 | -0.11 |
| 2024-12-10 | -0.11 |
| 2024-12-09 | -0.12 |
| 2024-12-06 | -0.11 |
| 2024-12-05 | -0.11 |
| 2024-12-04 | -0.12 |
| 2024-12-03 | -0.12 |
| 2024-12-02 | -0.13 |
| 2024-11-29 | -0.13 |
| 2024-11-27 | -0.13 |
| 2024-11-26 | -0.13 |
| 2024-11-25 | -0.13 |
| 2024-11-22 | -0.13 |
| 2024-11-21 | -0.13 |
| 2024-11-20 | -0.12 |
| 2024-11-19 | -0.12 |
| 2024-11-18 | -0.12 |
| 2024-11-15 | -0.12 |
| 2024-11-14 | -0.12 |
| 2024-11-13 | -0.12 |
| 2024-11-12 | -0.14 |
| 2024-11-11 | -0.13 |
| 2024-11-08 | -0.14 |
| 2024-11-07 | -0.14 |
| 2024-11-06 | -0.13 |
| 2024-11-05 | -0.13 |
| 2024-11-04 | -0.13 |
| 2024-11-01 | -0.13 |
| 2024-10-31 | -0.12 |
| 2024-10-30 | -0.13 |